ArticleProceedings of the National Academy of Sciences of the United States of America2024

AMBRA1 levels predict resistance to MAPK inhibitors in melanoma.

Luca Di Leo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.